Company / Net Income
Senti Biosciences Holdings, Inc. Net Income History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$52.8M
FY2025
5-year range
-$71.1M / -$52.8M
FY2022-FY2025
Trend
+25.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income returned to growth in FY2025 after 2 years of decline, reaching -$53M.
Based on SEC 10-K filings.
-$53M in FY2025.
Improved from -$58M to -$53M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 25.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$52.8M | +25.7% |
| FY2024 | -$71.1M | -22.1% |
| FY2023 | -$58.2M | -5.2% |
| FY2022 | -$55.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026